サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405813

ステントの市場規模、シェア、動向分析レポート：製品別、材料別、最終用途別、地域別、セグメント予測、2024年～2030年

Stents Market Size, Share & Trends Analysis Report By Product (Vascular, Non-vascular), By Material (Metallic, Non-metallic), By End-use (Hospitals, Ambulatory Care Centers, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ステントの市場規模、シェア、動向分析レポート：製品別、材料別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2023年12月07日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ステント市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のステントの市場規模は、2024年から2030年にかけてCAGR 3.8％を記録し、2030年までには184億6,000万米ドルに達する見込みです。

同市場の成長は、末梢血管疾患（PVD）や冠動脈疾患（CAD）などの慢性疾患の有病率の増加に起因しています。米国心臓協会（AHA）の「心臓病と脳卒中の統計-2022年最新版」によると、心血管疾患（CVD）は約1,905万人の世界の死亡原因となっています。

さらに、欧州委員会の推計によると、2022年の新規がん患者数は274万人に達し、2020年から2.3％増加すると予想されています。さらに、がんによる死亡者数は2020年と比較して2.4％増加すると予測されています。オーストラリア保健福祉研究所の報告によると、2020年から2021年の喘息による入院患者数は25,000人で、その割合は人口10万人あたり100人でした。0歳から14歳の子供の罹患率は225と、15歳以上の罹患率が68であるのに対し、有意に高いです。慢性疾患の有病率の上昇は、ステントの需要を押し上げると予想されます。

さらに、運動不足、喫煙、慢性的なストレスなどは、慢性疾患の発症に総体的に寄与する可能性があります。例えば、米国疾病予防管理センター（CDC）の報告によると、喫煙は肺がん関連死の約90％、慢性閉塞性肺疾患（COPD）関連死の約80％を引き起こしています。さらに、不健康なライフスタイルの採用が増加していることも、市場の成長をエスカレートさせると予想されます。

CDCの報告によると、2021年には18歳以上の米国成人の約11.5％、つまり100人中ほぼ12人が喫煙者です。これは、米国に住む推定2,830万人の成人がタバコを吸っていることを示しています。さらに、1,600万人以上のアメリカ人が喫煙に関連した疾病に罹患しています。このことは、市場の需要が拡大していることを示しています。さらに、主要な市場プレーヤーによるイニシアチブの高まりが、市場の成長を補うと思われます。2023年4月、TerumoはUltimaster Nagomiシロリムス溶出冠動脈ステントシステムの複雑なPCI患者を対象とした新たな臨床試験を開始しました。

ステント市場レポートハイライト

  • 製品別では、血管ステントセグメントが2023年の市場を独占し、88.40%の最大シェアを占めると考えられています。心血管疾患の有病率の増加が市場成長をエスカレートさせると予測されます。
  • 材料別では、金属ステント分野が2023年の市場で62.10%の大きなシェアを占めています。ステントの研究開発活動の活発化が市場成長を押し上げると予想されます。さらに、低侵襲処置への選好の高まりが、このセグメントの成長をさらに後押ししています。
  • 最終用途別では、病院が2023年の市場を独占し、74.24%の最大シェアを占めました。価値観に基づくヘルスケアの重視の高まりと経皮的冠動脈インターベンションの需要拡大が市場成長をエスカレートさせています。
  • 北米は2023年に主要地域に浮上し、43.69%の最大シェアを占めました。この地域では、冠動脈疾患や末梢動脈疾患など、生活習慣に関連した慢性疾患の有病率が増加しており、市場の成長を補完するものと思われます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場動向と展望
  • 市場力学
  • 市場抑制要因分析
  • 事業環境分析
    • SWOT分析;要因別（政治・法律、経済・技術）
    • ポーターのファイブフォース分析
  • COVID-19の影響分析

第4章 製品ビジネス分析

  • ステント市場、製品別：重要なポイント
  • ステント市場：製品動向と市場シェア分析、2022年・2030年
  • 血管ステント
    • 世界の血管ステント市場推計・予測、2018年～2030年
    • 冠状動脈ステント
    • 末梢ステント
    • 神経血管ステント
  • 非血管用ステント
    • 世界の非血管ステント市場推計・予測、2018年～2030年
    • 消化管ステント
    • 肺（気道）ステント
    • 泌尿器科用ステント
    • その他

第5章 材料ビジネス分析

  • ステント市場、材料別：重要なポイント
  • ステント市場：材料の動きと市場シェアの分析、2022年・2030年
  • 金属ステント
    • 世界の金属ステント市場推計・予測、2018年～2030年
  • 非金属ステント
    • 世界の非金属ステント市場推計・予測、2018年～2030年

第6章 最終用途ビジネス分析

  • 最終用途別のステント市場：重要なポイント
  • ステント市場：最終用途の動向と市場シェア分析、2022年・2030年
  • 病院
    • 世界の病院市場推計・予測、2018年～2030年
  • 外来治療センター（ACS）
    • 世界の外来治療センター
  • 専門クリニック
    • 世界の専門クリニック市場推計・予測、2018年～2030年

第7章 地域ビジネス分析

  • 地域市場のスナップショット
  • 国別の市場シェア分析、2022年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 北米
    • 北米のステント市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州のステント市場、2018年～2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋のステント市場、2018年～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカのステント市場、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカのステント市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業プロファイル・一覧表
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE &Co. KG
    • Biosensors International Group, Ltd.
    • Boston Scientific Corporation
    • Elixir Medical Corporation
    • Medtronic Plc
    • Meril Life Science
    • MicroPort Scientific Corporation
    • Stryker
    • Terumo Corporation
    • BD
    • WL Gore &Associates
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 4 Global Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 Global Stents Market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Stents Market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 9 North America Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 12 U.S. Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 15 Canada Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Stents Market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 18 Europe Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 19 Europe Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Germany Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 22 Germany Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 UK Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 25 UK Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 France Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 27 France Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 28 France Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 30 Italy Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 31 Italy Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Spain Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 33 Spain Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 34 Spain Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 36 Denmark Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 37 Denmark Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 39 Sweden Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 40 Sweden Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Norway Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 42 Norway Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 43 Norway Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Stents Market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 China Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 49 China Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 50 China Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Japan Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 53 Japan Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 India Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 55 India Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 56 India Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 South Korea Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 58 South Korea Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 59 South Korea Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Australia Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 62 Australia Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Thailand Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 64 Thailand Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 65 Thailand Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America Stents Market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 68 Latin America Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 69 Latin America Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Brazil Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 71 Brazil Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 72 Brazil Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Mexico Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 74 Mexico Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 75 Mexico Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 78 Argentina Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 84 South Africa Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 UAE Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 90 UAE Stents Market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Stents Market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Stents Market, by material, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Stents Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Stents Market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Stents Market: Product Outlook Key Takeaways
  • Fig. 15 Global Stents Market: Product Movement Analysis
  • Fig. 16 Global Vascular Stents Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Coronary Stents Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Peripheral Stents Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Neurovascular Stents Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Non-vascular Stents Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Gastrointestinal Stents Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Pulmonary (Airway) Stents Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Urological Stents Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Stents Market: Material Outlook Key Takeaways
  • Fig. 26 Global Stents Market: Material Movement Analysis
  • Fig. 27 Global Metallic Stents Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Non-metallic Stents Market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Stents Market: End-use Outlook Key Takeaways
  • Fig. 30 Global Stents Market: End-use Movement Analysis
  • Fig. 31 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Ambulatory Care Centers (ACS) Market, 2018 - 2030 (USD Million)
  • Fig. 33 Global Specialty Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional outlook, 2022 & 2030
  • Fig. 36 Global Stents Market: Region Movement Analysis
  • Fig. 37 North America Stents Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Stents Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Stents Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Stents Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Stents Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Stents Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Stents Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Stents Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Stents Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain Stents Market, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark Stents Market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden Stents Market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway Stents Market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia pacific Stents Market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan Stents Market, 2018 - 2030 (USD Million)
  • Fig. 52 China Stents Market, 2018 - 2030 (USD Million)
  • Fig. 53 India Stents Market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia Stents Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea Stents Market, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand Stents Market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America Stents Market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil Stents Market, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico Stents Market, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina Stents Market, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa Stents Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa Stents Market, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia Stents Market, 2018 - 2030 (USD Million)
  • Fig. 64 UAE Stents Market, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait Stents Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-163-4

Stents Market Growth & Trends:

The global stents market size is expected to reach USD 18.46 billion by 2030, registering a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to the increasing prevalence of chronic diseases, such as peripheral vascular diseases (PVDs) and coronary artery diseases (CAD). As per the American Heart Association (AHA) and their Heart Disease and Stroke Statistics - 2022 Update, cardiovascular disease (CVD) was responsible for around 19.05 million global fatalities.

Moreover, according to estimates by the European Commission, the number of new cancer cases is expected to reach 2.74 million in 2022, a 2.3% increase from 2020. Additionally, cancer deaths are predicted to rise by 2.4% when compared to 2020. As per the Australian Institute of Health and Welfare report, there were 25,000 hospitalizations for asthma in 2020-21, with a rate of 100 per 100,000 population. The rate among children aged 0-14 was significantly higher at 225 compared to 68 for those over 15. The escalating prevalence of chronic diseases is expected to boost the demand for stents.

Furthermore, physical inactivity, smoking, and chronic stress, among others, can collectively contribute to the development of chronic diseases. For instance, according to the Centers for Disease Control and Prevention (CDC) report, smoking is responsible for around 90% of lung cancer-related deaths and about 80% of chronic obstructive pulmonary disease (COPD) deaths. Additionally, the increasing adoption of unhealthy lifestyles is expected to escalate the market growth.

As per the CDC report, in 2021, approximately 11.5% of U.S. adults aged 18 years or older, which amounts to almost 12 out of every 100 people, are smokers. This indicates that an estimated 28.3 million adults residing in the U.S. smoke cigarettes. Additionally, more than 16 million Americans are affected by smoking-related diseases. This indicated the growing demand for the market. Moreover, the increasing initiatives undertaken by key market players will supplement market growth. In April 2023, Terumo started a new clinical study for the Ultimaster Nagomi sirolimus-eluting coronary stent system in patients undergoing complex PCI.

Stents Market Report Highlights:

  • Based on product, the vascular stents segment dominated the market in 2023, holding the largest share of 88.40%. The increasing prevalence of cardiovascular diseases is anticipated to escalate market growth
  • Based on material, the metallic stents segment held a significant share of 62.10% in the market in 2023. Increasing research and development activities in stents is expected to boost market growth. Moreover, the increasing preference for minimally invasive procedures further fueled the segment's growth
  • Based on end-use, hospitals dominated the market in 2023, representing the largest share of 74.24%. Increasing emphasis on value-based healthcare and the expanding demand for percutaneous coronary intervention are escalating the market growth
  • North America emerged as the leading region in 2023, holding the largest share of 43.69%. The increasing prevalence of lifestyle-related chronic diseases within the region, such as coronary artery disease and peripheral arterial disease, will supplement market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Restraint Analysis
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Stents Market, By Product: Key Takeaways
  • 4.2. Stents Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Vascular Stents
    • 4.3.1. Global Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Coronary Stents
      • 4.3.2.1. Global Coronary Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Peripheral Stents
      • 4.3.3.1. Global Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.2. Iliac Artery Stents
      • 4.3.3.2.1. Global Iliac Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. Femoral Artery Stents
      • 4.3.3.3.1. Global Femoral Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.4. Carotid Artery Stents
      • 4.3.3.4.1. Global Carotid Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.5. Renal Artery Stents
      • 4.3.3.5.1. Global Renal Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.6. Other Peripheral Stents
      • 4.3.3.6.1. Global Other Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Neurovascular Stents
      • 4.3.4.1. Global Neurovascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.2. Intracranial Stents
      • 4.3.4.2.1. Global Intracranial Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.3. Flow Diverters
      • 4.3.4.3.1. Global Flow Diverters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Non-vascular Stents
    • 4.4.1. Global Non-vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Gastrointestinal Stents
      • 4.4.2.1. Global Gastrointestinal Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Biliary
      • 4.4.2.2.1. Global Biliary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Duodenal
      • 4.4.2.3.1. Global Duodenal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.4. Colonic
      • 4.4.2.4.1. Global Colonic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.5. Pancreatic
      • 4.4.2.5.1. Global Pancreatic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.6. Esophageal Stents
      • 4.4.2.6.1. Global Esophageal Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Pulmonary (Airway) Stents
      • 4.4.3.1. Global Pulmonary (Airway) Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.2. Silicone Airway
      • 4.4.3.2.1. Global Silicone Airway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.3. Metallic Airway
      • 4.4.3.3.1. Global Metallic Airway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Urological Stents
      • 4.4.4.1. Global Urological Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Material Business Analysis

  • 5.1. Stents Market, By Material: Key Takeaways
  • 5.2. Stents Market: Material Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Metallic Stents
    • 5.3.1. Global Metallic Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Non-metallic Stents
    • 5.4.1. Global Non-metallic Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis

  • 6.1. Stents Market, By End-use: Key Takeaways
  • 6.2. Stents Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Ambulatory Care Centers (ACS)
    • 6.4.1. Global Ambulatory Care Centers (ACS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Specialty Clinics
    • 6.5.1. Global Specialty Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. Market Share Analysis by Country, 2022
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. MEA
  • 7.3. North America
    • 7.3.1. North America Stents Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. U.S. Stents Market, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Canada Stents Market, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Stents Market, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Germany Stents Market, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. UK Stents Market, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. France Stents Market, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Italy Stents Market, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Spain Stents Market, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Denmark Stents Market, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Sweden Stents Market, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Norway Stents Market, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Stents Market, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Japan Stents Market, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. China Stents Market, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. India Stents Market, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. South Korea Stents Market, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Australia Stents Market, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Thailand Stents Market, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Stents Market, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Brazil Stents Market, 2018 - 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Mexico Stents Market, 2018 - 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Argentina Stents Market, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Stents Market, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. South Africa Stents Market, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Saudi Arabia Stents Market, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. UAE Stents Market, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Kuwait Stents Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Profiles/Listing
    • 8.3.1. Abbott Laboratories
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. B. Braun Melsungen AG
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Biotronik SE & Co. KG
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Biosensors International Group, Ltd.
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Boston Scientific Corporation
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Elixir Medical Corporation
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Medtronic Plc
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Meril Life Science
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.8.3. Platform Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. MicroPort Scientific Corporation
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.9.3. Platform Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Stryker
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.10.3. Platform Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Terumo Corporation
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.11.3. Platform Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. BD
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.12.3. Platform Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. W.L Gore & Associates
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.3.13.3. Platform Benchmarking
      • 8.3.13.4. Strategic Initiatives